VEGFA and cancer: In addition to their cytotoxic activity, HNP-1 and -3 may be able to interfere with neovascularisation during cancer development because these α-defensins inhibit the α5β1 integrin-dependent migration and adhesion of endothelial cells to fibronectin in response to vascular endothelial growth factor (VEGF) [84].